66949-23-3

Upstream product

• 100-97-0 hexamethylenetetramine 
• 23203-13-6 1-methyl-2-chloromethyl-4-(1,1-dimethylethyl)benzene 
• 7397-06-0 4-t-butyl-o-xylene 
• 61024-94-0 2-bromo-4-tert-butyl-1-methylbenzene 
• 122-51-0 orthoformic acid triethyl ester 
• 68-12-2 N,N-dimethyl-formamide 
• 98-51-1 4-tert-butyltoluene 

Downstream Products

• 99758-71-1 5-tert-butyl-2-methyl-3-nitro-benzaldehyde 
• 143121-12-4 1,6-bis(5-tert-butyl-2-methylphenyl)hexane 
• 351352-74-4 (E)-2-bromo-4,5'-di-tert-butyl-2'-methylstilbene 
• 351353-40-7 (E)-1-(8-bromo-4,6-di-tert-butyl-1-phenanthryl)-2-(5'-tert-butyl-2'-methylphenyl)ethene 
• 958261-59-1 C₂₄H₃₄O₂ 
• 110891-15-1 1,4-bis(5-tert-butyl-3-chloromethyl-2-methylphenyl)butane 
• 110891-10-6 1,3-bis(5-tert-butyl-3-chloromethyl-2-methylphenyl)propane 
• 110891-14-0 1,4-bis(5-tert-butyl-2-methylphenyl)butane 
• 108656-60-6 1,3-bis(5-tert-butyl-2-methylphenyl)propane 
• 23203-17-0 3-(5-tert-butyl-2-methylphenyl)propionic acid 
• 23203-23-8 4-tert-butyl-2-(3-hydroxypropyl)toluene 
• 23203-24-9 4-tert-butyl-2-(3-bromopropyl)toluene 
• 253185-03-4 tert-butylbenzene 

Relevant academic research and scientific papers

INTEGRIN ANTAGONISTS

The present disclosure provides pharmaceutical agents, including those of the formula:(I) wherein the variables are defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such pharmaceutical agents. Meth

Phenacenes: A family of graphite ribbons. Part 3: Iterative strategies for the synthesis of large phenacenes

Iterative strategies are reported for the synthesis of some large monodisperse [n]phenacenes, which are polycyclic aromatic hydrocarbon derivatives having n benzene rings fused in an extended phenanthrene-like structural motif. The key carbon-carbon bond-